Alaa Shahbar

10PUBLICATIONS
9CO-AUTHORS
Haematological tumoursClinical pharmacy and pharmacy practiceCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 26, 2026
Safety of Immune Checkpoint Inhibitors in Hepatitis B Virus-Positive Cancer Patients: A Multicenter Retrospective Cohort Study.

|Feb 20, 2026
Pharmacists' Work Experiences and Career Dynamics in Saudi Arabia: A Cross-Sector Study.

Mohammed Alnuhait, Ayidh Alqarni, Leena Alsharafi

|Feb 13, 2026
Safety and Efficacy of Direct Oral Anticoagulants Versus Standard Therapy for Venous Thromboembolism in Cancer Patients: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials.

Alaa Shahbar, Sabah Alshahrani, Abdullah Alhifany

|Aug 20, 2025
Cardiovascular safety of CDK4/6 inhibitors in advance breast cancer: Assessing risks of QTc prolongation and thrombosis.

Alaa Shahbar

|May 14, 2025
Clinical Trial Awareness, Perceptions, and Participation Among Cancer Patients in Saudi Arabia.

Maryam Alotaibi, Laila Alsolami, Sarah AlHarbi

|Apr 26, 2025
Venous Thromboembolism in Cancer: Predictors of Recurrence and Bleeding in Patients on Direct Oral Anticoagulants.

Alaa Shahbar, Afnan Noor, Alqassem Y Hakami

Pageof 2

Frequent Collaborators

6 joint publications

Mohammed Alnuhait

2 joint publications

Alqassem Y Hakami

2 joint publications

Abdulfattah Y Alhazmi

1 joint publications

Mansoor Ahmed Khan